3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Interpeduncular-Ventral Hippocampus Pathway Mediates Active Stress Coping and Natural Reward

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Maladaptive stress-related behaviors are integral to multiple complex psychiatric disorders, and it has been well established that serotonergic signaling mediates various aspects of these maladaptive states. In these studies, we sought to uncover the function of a previously undefined serotonergic pathway, which projects from the interpeduncular nucleus (IPN) to the ventral hippocampus (vHipp). Intersectional retrograde and chemogenetic viral manipulation strategies were employed to manipulate the function of the IPN-vHipp pathway during a variety of behavioral measures in male mice. We found a significant effect of circuit inhibition on behaviors associated with coping strategies and natural reward. Specifically, inhibition of the IPN-vHipp pathway dramatically increased active stress-induced escape behaviors, in addition to moderately affecting sucrose consumption and food self-administration. During inhibition of this pathway, agonist activation of serotonergic 5-HT 2A/2C receptors in the vHipp reversed the effects of IPN-vHipp circuit inhibition on active escape behaviors, thereby supporting the synaptic mechanism underlying the behavioral effects evidenced. IPN-vHipp inhibition did not induce differences in generalized locomotion, anxiety-associated behavior, and intravenous nicotine self-administration. Importantly, these findings are in opposition to the canonical understanding of serotonin in such escape behaviors, indicating that serotonin exerts opposing effects on behavior in a pathway-specific manner in the brain. Taken together, these findings thereby have important implications for our understanding of serotonergic signaling and associated therapeutic approaches for the treatment of disease symptomology.

          Related collections

          Most cited references76

          • Record: found
          • Abstract: not found
          • Article: not found

          Moving beyond P values: data analysis with estimation graphics

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.

            We evolved muscarinic receptors in yeast to generate a family of G protein-coupled receptors (GPCRs) that are activated solely by a pharmacologically inert drug-like and bioavailable compound (clozapine-N-oxide). Subsequent screening in human cell lines facilitated the creation of a family of muscarinic acetylcholine GPCRs suitable for in vitro and in situ studies. We subsequently created lines of telomerase-immortalized human pulmonary artery smooth muscle cells stably expressing all five family members and found that each one faithfully recapitulated the signaling phenotype of the parent receptor. We also expressed a G(i)-coupled designer receptor in hippocampal neurons (hM(4)D) and demonstrated its ability to induce membrane hyperpolarization and neuronal silencing. We have thus devised a facile approach for designing families of GPCRs with engineered ligand specificities. Such reverse-engineered GPCRs will prove to be powerful tools for selectively modulating signal-transduction pathways in vitro and in vivo.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Neurobiology of Depression

                Bookmark

                Author and article information

                Journal
                eNeuro
                eNeuro
                eneuro
                eneuro
                eNeuro
                eNeuro
                Society for Neuroscience
                2373-2822
                30 October 2020
                16 November 2020
                Nov-Dec 2020
                : 7
                : 6
                : ENEURO.0191-20.2020
                Affiliations
                [1]Department of Neurobiology and Behavior, University of California Irvine , Irvine, CA 92697
                Author notes

                The authors declare no competing financial interests.

                Author contributions: Y.S. and C.D.F. designed research; Y.S., M.B., J.P.F., E.C., A.A., and C.D.F. performed research; Y.S., M.B., and C.D.F. analyzed data; Y.S., M.B., J.P.F., E.C., A.A., and C.D.F. wrote the paper.

                This work was supported by grants from the National Institutes of Health National Institute on Drug Abuse Grants K99/R00 DA032543 and DP1 DA039658 (to C.D.F.) and F31 DA050436 (to Y.S.).

                Correspondence should be addressed to Christie D. Fowler at cdfowler@ 123456uci.edu .
                Author information
                https://orcid.org/0000-0002-7073-9279
                https://orcid.org/0000-0003-2864-2163
                Article
                eN-NWR-0191-20
                10.1523/ENEURO.0191-20.2020
                7688303
                33139320
                ca35b3b5-a29e-4c76-bf9b-e34ee90c5bc6
                Copyright © 2020 Sherafat et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 12 May 2020
                : 24 September 2020
                : 26 October 2020
                Page count
                Figures: 5, Tables: 2, Equations: 0, References: 77, Pages: 17, Words: 00
                Funding
                Funded by: http://doi.org/10.13039/100000026HHS | NIH | National Institute on Drug Abuse (NIDA)
                Award ID: DA032543
                Award ID: DA039658
                Award ID: DA050436
                Categories
                1
                Research Article: New Research
                Cognition and Behavior
                Custom metadata
                November/December 2020

                anhedonia-associated behavior,hippocampus,interpeduncular nucleus,serotonin,stress coping behavior

                Comments

                Comment on this article